Given a paragraph and a claim, classify it this way: If the claim contradicts the evidence present in the paragraph, classify the claim as '0'. If the claim has multiple supporting *AND* contradicting evidences, classify the claim as '1'. If the claim has supporting evidence and the paragraph is in overall favor of the claim, then classify the claim as '2'.

[EX Q]: Paragraph: Q: Did an FDA-approved form of “synthetic marijuana” lead to recent deaths in Illinois? A: No. The drugs that have killed four people in the last two months are unregulated and illegal. Four people have died after using drugs made to imitate the high of marijuana in Illinois over the last two months. That’s true.It’s not true that the drugs they used were approved by the Food and Drug Administration, as was claimed by a story circulating on Facebook under the headline: “Big Pharma Synthetic Marijuana Leaves 2 Dead, 89 Hospitalized In Illinois.”The number of those who died is wrong in the headline because the story was copied, for the most part, from a legitimate report that was published on April 6, when that number was accurate.The recent story that Facebook users flagged as potentially false comes from a site registered to an owner in Pakistan and differs in a couple of important ways from the original. It has a misleading headline (indicating that the drugs were made by regulated pharmaceutical manufacturers) and it starts out with a sentence that is wrong.It says at the top: “The users ingested an FDA-approved version of synthetic cannabis known as K2 or Spice.”That’s not true.The FDA has approved three drugs with synthetic versions of chemicals similar to or the same as those found in marijuana — Marinol, Syndros, and Cesamet can be used to help with nausea from cancer treatments and Marinol and and Syndros can also be used to treat weight loss in AIDS patients. The FDA is currently reviewing another drug related to marijuana that would treat epilepsy.Neither “K2” nor “Spice” has been approved by the FDA, administration spokesman Michael Felberbaum confirmed.Not only are they not approved by the FDA, those are two of the most common names under which imitation marijuana is sold. A Drug Enforcement Administration official, Susan Gibson, used them as an example when she testified in front of Congress earlier this year, saying, “Synthetic cannabinoids and their byproducts (sometimes sold under brand names such as K2 or Spice) continue to be a significant threat to public health and safety.”Synthetic cannabinoids are typically sprayed onto dried plant material and smoked or used in e-cigarettes to achieve a high similar to marijuana, but their effects can be unpredictable and dangerous, according to the National Institute on Drug Abuse. The drugs used in the recent spate of overdoses in Illinois and surrounding states included a chemical found in rat poison, according to the Illinois Department of Public Health and the Centers for Disease Control and Prevention.NIDA: These chemicals are called cannabinoids because they are similar to chemicals found in the marijuana plant. Because of this similarity, synthetic cannabinoids are sometimes misleadingly called “synthetic marijuana” (or “fake weed”), and they are often marketed as safe, legal alternatives to that drug. In fact, they are not safe and may affect the brain much more powerfully than marijuana; their actual effects can be unpredictable and, in some cases, more dangerous or even life-threatening.The chemical composition of imitation marijuana can vary, which makes legislating against it difficult, although all 50 states have banned some form of synthetic cannabinoids, according to the National Conference of State Legislatures. In Illinois, imitation marijuana is illegal under two laws — one that was passed specifically to address those drugs and under the state’s Controlled Substances Act, according to Eileen Boyce, spokeswoman for the Illinois attorney general.In April 2017 the DEA temporarily added chemical compounds often used in imitation marijuana to the list of schedule 1 controlled substances, citing overdoses on the increasingly popular drug as the reason. Those compounds are set to remain on the list until April 10, 2019.So, if you’ve read the story traveling around Facebook and gotten the impression that people are dying from legal, regulated medications related to marijuana — they’re not. The imitation marijuana that is killing people is unregulated and illegal.Editor’s note: FactCheck.org is one of several organizations working with Facebook to debunk false stories flagged by readers on the social media network.Illinois Department of Public Health. WARNING: Synthetic Cannabinoids Linked to Bleeding. Accessed 17 May 2018.“Big Pharma Synthetic Marijuana Leaves 2 Dead, 89 Hospitalized In Illinois.” Trendsadays.com. 15 May 2018.Tomoski, Miroslav. “89 hospitalized and 2 dead in Illinois after using synthetic marijuana.” Herb.co. 6 Apr 2018.Gibson, Susan. Statement for hearing entitled “COMBATING THE OPIOID CRISIS: HELPING COMMUNITIES BALANCE ENFORCEMENT AND PATIENT SAFETY.” 28 Feb 2018.Felberbaum, Michael. Spokesman, Food and Drug Administration. Interview with FactCheck.org. 17 May 2018.National Institute on Drug Abuse. Drug facts — Synthetic Cannabinoids (K2/Spice). Feb 2018.National Conference of State Legislatures. Emerging Drug Threats. 7 Jun 2017.Illinois Department of Public Health. “Fourth Death Related to Synthetic Cannabinoids.” 24 Apr 2018.Centers for Disease Control and Prevention. Outbreak Alert: Potential Life-Threatening Vitamin K-Dependent Antagonist Coagulopathy Associated With Synthetic Cannabinoids Use. 5 Apr 2018.Boyce, Eileen. Spokeswoman, Illinois Office of the Attorney General. Interview with FactCheck.org. 17 May 2018.Federal Register. Schedules of Controlled Substances: Temporary Placement of Six Synthetic Cannabinoids (5F-ADB, 5F-AMB, 5F-APINACA, ADB-FUBINACA, MDMB-CHMICA and MDMB-FUBINACA) into Schedule I. 10 Apr 2017. Claim: "FDA-approved ""synthetic marijuana"" leads to deaths in Illinois."
[EX A]: 0

[EX Q]: Paragraph: "Hillary Clinton's near-collapse at a Sept. 11 memorial service and the subsequent revelation that she had been diagnosed with pneumonia two days earlier has people wondering about the health of the two major presidential candidates. The Clinton campaign promised more medical data on her health, and Republican Donald Trump pledged to release details of a recent checkup. Both candidates have already released letters from their doctors saying they are healthy enough to be president. Clinton’s team argues that Trump has released less information about his health than Clinton. In an interview with Anderson Cooper on CNN, Clinton said her two-page 2015 letter from her physician is consistent with what presidential candidates have released in the past. ""You know, you've got a medical report on me that meets the same standard as Mitt Romney and Barack Obama"" when the two ran for president, Clinton said. ""Donald Trump's doctor said he'd be the healthiest president in history. That's just not even serious."" When Cooper asked what additional information she would be supplying, Clinton did not offer any details. ""Well, we're going to be releasing more information, and I think it's fair to say, we've already met the standard of disclosure of past presidential candidates like Mitt Romney and President Obama."" Actually, there is no ""standard"" for the type of medical information that should be released. The experts we consulted agreed. But Clinton's disclosures are on the same level as Obama and Romney in previous elections. ""There is no 'standard' of medical disclosure, just whatever the voting public is comfortable with,"" said Jerald Podair, professor of history at Lawrence University in Wisconsin. ""This means, of course, that as much secrecy as possible has been the historical norm."" Thus, he said, the public didn't know about Grover Cleveland's cancer, Franklin Roosevelt's paralysis or John Kennedy's Addison’s disease. ""All kept the true nature of their illnesses secret from the American public. Obviously, is is harder to do so today, but as Hillary (‘darn these allergies’) Clinton has shown, the system can still be gamed."" ""This is an imaginary standard set up by candidates,"" said Brooks Simpson, a presidential historian at Arizona State University. Interest in candidate medical records has varied over time. There was a lot of interest when John McCain ran against Obama in 2008. McCain was 71 and had a history of skin cancer. He released 1,173 pages of records going back to 2000. In contrast, medical records were not much of an issue in 2004 when George W. Bush, then 58, sought re-election against John Kerry, then 60. Both were known to be big fitness enthusiasts. Bush had received regular checkups as president but that year decided to have his physical after the election. As CNN reported at the time, ""Neither President Bush nor Senator Kerry have released their full medical records, but there isn't much public pressure for either man to release more details. Americans may want a healthy commander-in-chief, but 61 percent say the president has the same rights as other citizens to keep medical records private, compared to just 38 percent in favor of releasing all information that might affect his ability to serve."" It's more of an issue today, in part, because both candidates are so old. ""These people are in the Ronald Reagan category,"" said Simpson. Trump, if elected, would be the oldest person to assume the presidency. Clinton would be the second oldest behind Reagan. ""Maybe 70 is the new 60, but these people are old,"" Simpson said. ""Neither one has really satisfied issues of disclosure in the public mind,"" although Clinton has been more forthcoming, he said. ""Trump's efforts have been pretty feeble. But the incident on Sunday and the cough just illustrated a personal attack narrative and has given traction to an accusation that her health is less than ideal. This is a way not just to raise questions about candidate health, but about candidate transparency."" When we contacted the Clinton campaign, spokesman Josh Schwerin acknowledged that there is no real standard. He said the candidate was simply referring to the examples of Obama and Romney as a relevant point of comparison. How do their medical summaries compare? Candidate Obama Romney Clinton Trump Year 2008 2012 2015 2015 Words in doctor letter 280 535 578 174 Blood pressure 90/60 130/80 100/65 110/65 Heart rate 60 40 72 Not mentioned Triglycerides 44 179 69 Not mentioned Total cholesterol 173 169 195 Not mentioned Good cholesterol 68 Not mentioned 64 Not mentioned Bad cholesterol 96 Not mentioned 118 Not mentioned Prostate-specific antigen (PSA) 0.6 Normal Not relevant .015 Allergies mentioned? No Yes Yes No Past health problems detailed? No Yes Yes Yes Family history mentioned? Yes Yes Yes No Because there is no standard, the doctors of different candidates included different levels of detail. The letters for all four candidates gave blood pressure. The letters for Obama, Romney and Clinton offered at least some blood test results, such as total cholesterol. Trump's does not. Family history, a key factor for predicting a person's lifespan or potential health problems, is missing from Trump's letter. The doctors for Clinton and Romney go into more detail about the candidate's past health problems, but that may be because they had some issues in the past. We don't know about Trump's history, but the detailed 2014 health report for Obama once he became president says he's had no significant medical problems, including no surgeries. The most detailed template was Obama’s annual presidential physical. The 2014 report contains far more information than he released when he first ran in 2008. It talks about immunizations. It lists medications (without giving doses), a fasting blood sugar level and cholesterol counts. There's also discussion of the status of his heart, lungs, eyes, head neck, bones, muscles, nerves and skin. ""Probably Hillary is about right since the standard is that most politicians conceal their debilitating illnesses or fabricate (maybe exaggerate) how wonderfully healthy they are,"" said Bert Rockman, professor emeritus of political science at Purdue University. Because of their age, ""there is bound to be something wrong with each of them despite Trump's likely-dictated note to his doctor, which meets the standard of a school boy note."" ""Of course, some candidates are in terrific shape — Romney and Obama, for example, and Carter,"" he said. ""And you likely wouldn't run for president if you were seriously (physically) debilitated,"" putting the cases of Kennedy and Roosevelt aside. ""In other words,"" said Rockman, ""the bar is really low, and Hillary likely met it by historical standards."" Our ruling Clinton said, ""You've got a medical report on me that meets the same standard as Mitt Romney and Barack Obama."" If Romney and Obama exemplify a standard, then the information Clinton has provided to the public is on a comparable level. But Clinton's statement implies a standard that doesn’t really exist, according to the experts. And both the quality and quantity of information on presidential candidates has varied widely. Claim: You've got a medical report on me that meets the same standard as Mitt Romney and Barack Obama.
[EX A]: 2

[EX Q]: Paragraph: P&G, with roughly $68 billion in annual revenue, said it has invested millions in creating and testing refills for detergents over the years and is now trying to push in to mainstream beauty and body care refills – which are virtually  unheard of. It recently began offering some Olay face-cream jars with refill pouches on Olay.com, telling Reuters it has plans to expand the sales of the pouches in Europe early next year. “We’re learning on our legs so I don’t know that we’re in a position to say, ‘Hey, here’s the magic to selling refills,’” P&G spokesman Damon Jones said. Beauty products retailer The Body Shop, owned by Brazil’s Natura Cosmeticos SA NATU3.SA, says it plans to roll out “refill stations” in its stores globally next year, allowing shoppers to buy reusable metal containers to fill with Body Shop shower gels or creams. The company had offered refills at its stores in the early 1990s, but discontinued them in 2003, citing a lack of consumer demand. Unilever, which has set targets for reducing and recycling plastic by 2025, in October announced the planned launch of “refill sticks” of deodorants under its Dove line of personal care products on Loopstore.com. The website, operated by recycling company TerraCycle, offers consumers the chance to buy some household products in ultra-durable packaging with refills delivered to their doors, milkman-style. Across the consumer goods industry, results for refillable products have been mixed so far as many shoppers are far too set in their ways to be easily weaned from living in a throwaway culture. While refills are less expensive to purchase - generally priced at 20% to 30% less per item than the containers they are aimed to replenish, according to Unilever - shoppers have so far, for the most part, failed to snap them up, the companies said. SC Johnson & Son Inc, marketer of Windex and Pledge, said refills and concentrates so far have not played well with either Americans or Europeans over the decade they have been offered, with unit sales of such products pretty much flat. It pulled concentrated refills for Shout stain remover off the shelves because they were not selling very well. In 2010, Unilever put 20-liter tanks to dispense detergents in Walmart Inc’s (WMT.N) British supermarket chain Asda, and provided flexible pouches for customers to refill. But with leaky machines, safety and maintenance problems and the high costs of upkeep, Unilever said the tests fell short of expectations. Asda was also unhappy because the tanks occupied a lot of space. “None of them sell very well – it is a convenience issue,” SC Johnson CEO Fisk Johnson told Reuters. Johnson said some people find it painstaking to wash and refill bottles themselves while others worry that smaller bottles filled with concentrates are less “bang-for-your-buck” than the larger ones they have used for years. Still, the privately held company said it was expanding its refill offerings this year to address concerns surrounding plastic waste and is also testing refill stations for cleaning products with UK retailer Waitrose, owned by Britain’s John Lewis [JLPLC.UL]. The Waitrose tests are showing the first signs of progress in refill sales, Johnson said, and the company is now thinking of expanding the project. Even if consumers are comfortable using refills for some household goods, it is more complicated to sell them for products like Pantene shampoo and Olay creams, P&G spokesman Jones said. For instance, with beauty products, the look and feel of packaging is a big factor in creating and maintaining customer loyalty, while delivering an environmental benefit, he said. Some shoppers say they want to buy refillable products, but that the offerings are not available at many stores. Earlier this year, dozens of consumers took to social media to urge The Body Shop to bring back its refill counters. “Refill, refill, refill!” Twitter user @JaiChipperfield said on July 22, joining a thread in which several other shoppers demanded the return of refills. “Seems to me that judging by these comments your customers want to see the return of refills,” @JaiChipperfield added. “Me too, it would be brilliant to see that return.”  The Body Shop eventually responded to those pleas. “Now with the renewed focus on sustainability, we believe it is the right time to return with it,” Body Shop spokeswoman Lucy Muircroft told Reuters this week. Claim: Procter & Gamble, rivals take refills into beauty aisle.
[EX A]:
2